News
- Clinical research center conducts clinical trial of Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies
- Canadian University carries out resistance training for men living with Obesity
- US company started clinicl trial of Tissue Collection to ID TCRs From Renal Clear Cell Carcinoma Patients Responding to Immune Checkpoint Inhibitors
- WHO supports European countries’ response to new virus variant
- Health Canada authorizes Moderna COVID-19 vaccine
- Government of Canada provides $70 million in additional funding to the Red Cross for ongoing COVID-19 response
- Trump Administration purchases additional 100 million doses of COVID-19 investigational vaccine from Pfizer
- HHS, DOD collaborate with Merck to continue the development and large-scale manufacturing of investigational COVID-19 treatment
- Results of NIH-sponsored ACTIV-3 trial published
- FDA Warns Companies Illegally Selling CBD Products
- Joint statement calling for urgent country scale-up of access to optimal HIV treatment for infants and children living with HIV
- Progress Update: WHO 1+1 Initiative and Implementation of Youth Declaration to End TB
- European University started clinical trial of Implementation of a Respiratory Physiotherapy Program in Post COVID-19 Patients Through Tele-assistance
- Medicine company evaluates safety, engraftment and efficacy of VC-01 in patients with T1 Diabetes Mellitus
- US Cancer Center started clinical trial of Exercise Program for the Improvement of Movement and Mobility in Patients With Cancer Undergoing a Blood Stem Cell Transplant
- Cancer Center conducts Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer
- FDA Warns Consumers to Avoid Certain Male Enhancement and Weight Loss Products Sold Through Amazon, eBay and Other Retailers Due to Hidden, Potentially Dangerous Drug Ingredients
- WHO and EU join together to support COVID-19 response and systems strengthening in Asia
- New COVID-19 strain: What do we know to date?
- FDA Approves First Oral Hormone Therapy for Treating Advanced Prostate Cancer
- WHO promotes distance care for diabetic patients in Czechia during COVID-19
- FDA Approves Prosthetic Implant for Above-the-Knee Amputations
- Turning the tide: Slovenia’s success story of fighting cervical cancer
- EMA recommends first COVID-19 vaccine for authorisation in the EU
- WHO analytical tool helps Ukraine monitor how regions respond to COVID-19
Clinical Research News
Bevorstehende klinische Studien
-
Aperta Biosciences, LLCNoch keine Rekrutierung
-
Hospices Civils de LyonNoch keine RekrutierungHarninkontinenz | Neurogene Blasen | Harnableitung | Beckenmalignität | HarnblasenkarzinomFrankreich
-
Second Affiliated Hospital, Zhejiang University...RekrutierungNormales Gehör | Lärmbelastung | Preferred Loudness LevelChina
-
Qilu Pharmaceutical Co., Ltd.Noch keine RekrutierungKlarzelliges Nierenzellkarzinom | Eierstockkrebs | Andere fortgeschrittene solide TumorenChina
-
University Hospital, AntwerpNoch keine RekrutierungNekrotisierende Enterokolitis des Neugeborenen | Neugeborenen-Sepsis mit spätem BeginnBelgien, Niederlande
-
VA Office of Research and DevelopmentNoch keine RekrutierungMetastasierender nicht-kleinzelliger Lungenkrebs | Cancer-Associated Weight Loss | Elevated Inflammatory MarkersVereinigte Staaten
-
ENTire Medical Ltd.Noch keine RekrutierungHypertrophie | Tonsillektomie | Obstruktion der Atemwege oben | Adenoidektomie-ChirurgieVereinigte Staaten
-
AbbVieNoch keine RekrutierungMittelschwere bis schwere Psoriasis
-
Institute of Hematology & Blood Diseases Hospital...RekrutierungAplastische Anämie | Klonale Hämatopoese | Immunsuppressive TherapieChina
-
Ahmed Nasser Ali MabkhoutRekrutierungKieferzysten | Alveolar Bone DefectsJemen
-
University of CoimbraNoch keine Rekrutierung
-
AbbVieNoch keine Rekrutierung
